Home > Resources > The strengths of electronic Clinical Outcome Assessment (eCOA) versus paper solutions

The strengths of electronic Clinical Outcome Assessment (eCOA) versus paper solutions

eCOA Scientific advice

5 February 2024

In contrast to paper solutions, electronic Clinical Outcome Assessment (eCOA) demonstrates strengths such as:

Accuracy
Completeness
Timings
Attributability
User-friendliness
Regulatory compliance

#electronic Clinical Outcome Assessment #eCOA #clinical trial

Subscribe to our newsletter

Rare disease clinical research: it is time to tackle what...

The client’s voice: why they consistently choose Kayentis

Why you should join Kayentis

Rethinking pediatric clinical trials: guidelines from pediatric experts

Overcoming challenges in long-lasting pediatric clinical trials – Insights from...

Tackling the specificities of NASH/MASH clinical trials

About the author

Marc Chaperon

Estelle brings 20+ years of experience in pre-clinical and clinical research from Top 5 Pharma and Biotech firms. Leading projects across Phases 1 to 4 in diverse therapeutic areas, she offers deep insights into clinical science, operations, and regulatory intricacies. Appointed as Chief Medical Officer at Kayentis in May 2019.

Meet us at the following events

No articles found.